Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 2
2003 5
2004 6
2005 4
2006 8
2007 3
2008 5
2009 7
2010 9
2011 17
2012 18
2013 17
2014 14
2015 13
2016 9
2017 7
2018 13
2019 11
2020 9
2021 9
2022 7
2023 11
2024 11
2025 7
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

200 results

Results by year

Filters applied: . Clear all
Page 1
Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer.
Zhang K, Erkan EP, Jamalzadeh S, Dai J, Andersson N, Kaipio K, Lamminen T, Mansuri N, Huhtinen K, Carpén O, Hietanen S, Oikkonen J, Hynninen J, Virtanen A, Häkkinen A, Hautaniemi S, Vähärautio A. Zhang K, et al. Among authors: hautaniemi s. Sci Adv. 2022 Feb 25;8(8):eabm1831. doi: 10.1126/sciadv.abm1831. Epub 2022 Feb 23. Sci Adv. 2022. PMID: 35196078 Free PMC article.
Chemotherapy induces myeloid-driven spatially confined T cell exhaustion in ovarian cancer.
Launonen IM, Niemiec I, Hincapié-Otero M, Erkan EP, Junquera A, Afenteva D, Falco MM, Liang Z, Salko M, Chamchougia F, Szabo A, Perez-Villatoro F, Li Y, Micoli G, Nagaraj A, Haltia UM, Kahelin E, Oikkonen J, Hynninen J, Virtanen A, Nirmal AJ, Vallius T, Hautaniemi S, Sorger PK, Vähärautio A, Färkkilä A. Launonen IM, et al. Among authors: hautaniemi s. Cancer Cell. 2024 Dec 9;42(12):2045-2063.e10. doi: 10.1016/j.ccell.2024.11.005. Cancer Cell. 2024. PMID: 39658541 Free article.
A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids.
Senkowski W, Gall-Mas L, Falco MM, Li Y, Lavikka K, Kriegbaum MC, Oikkonen J, Bulanova D, Pietras EJ, Voßgröne K, Chen YJ, Erkan EP, Dai J, Lundgren A, Grønning Høg MK, Larsen IM, Lamminen T, Kaipio K, Huvila J, Virtanen A, Engelholm L, Christiansen P, Santoni-Rugiu E, Huhtinen K, Carpén O, Hynninen J, Hautaniemi S, Vähärautio A, Wennerberg K. Senkowski W, et al. Among authors: hautaniemi s. Dev Cell. 2023 Jun 19;58(12):1106-1121.e7. doi: 10.1016/j.devcel.2023.04.012. Epub 2023 May 5. Dev Cell. 2023. PMID: 37148882 Free PMC article.
Evolutionary states and trajectories characterized by distinct pathways stratify patients with ovarian high grade serous carcinoma.
Lahtinen A, Lavikka K, Virtanen A, Li Y, Jamalzadeh S, Skorda A, Lauridsen AR, Zhang K, Marchi G, Isoviita VM, Ariotta V, Lehtonen O, Muranen TA, Huhtinen K, Carpén O, Hietanen S, Senkowski W, Kallunki T, Häkkinen A, Hynninen J, Oikkonen J, Hautaniemi S. Lahtinen A, et al. Among authors: hautaniemi s. Cancer Cell. 2023 Jun 12;41(6):1103-1117.e12. doi: 10.1016/j.ccell.2023.04.017. Epub 2023 May 18. Cancer Cell. 2023. PMID: 37207655 Free article.
Decoding the Genomic and Functional Landscape of Emerging Subtypes in Ovarian Cancer.
Micoli G, Lavikka K, Li Y, Pirttikoski A, Afenteva D, Senkowski W, Marchi G, Vähärautio A, Muranen TA, Joutsiniemi T, Hietanen S, Virtanen A, Wennerberg K, Hynninen J, Oikkonen J, Hautaniemi S. Micoli G, et al. Among authors: hautaniemi s. Cancer Discov. 2025 Nov 3;15(11):2262-2277. doi: 10.1158/2159-8290.CD-25-0652. Cancer Discov. 2025. PMID: 40736012 Free PMC article.
Diverse oncogenes use common mechanisms to drive growth of major forms of human cancer.
Kauko O, Turunen M, Pihlajamaa P, Häkkinen A, Queiroz RML, Pääkkönen M, Ventelä S, Gaetani M, Lundström SL, Murgia A, Sahu B, Routila J, Wei GH, Irjala H, Griffin JL, Lilley KS, Kivioja T, Hautaniemi S, Taipale J. Kauko O, et al. Among authors: hautaniemi s. Sci Adv. 2025 Aug 22;11(34):eadt1798. doi: 10.1126/sciadv.adt1798. Epub 2025 Aug 20. Sci Adv. 2025. PMID: 40834066 Free PMC article.
Multi-omics analysis reveals the attenuation of the interferon pathway as a driver of chemo-refractory ovarian cancer.
Afenteva D, Yu R, Rajavuori A, Salvadores M, Launonen IM, Lavikka K, Zhang K, Pirttikoski A, Marchi G, Jamalzadeh S, Isoviita VM, Li Y, Micoli G, Erkan EP, Falco MM, Ungureanu D, Lahtinen A, Oikkonen J, Hietanen S, Vähärautio A, Sur I, Virtanen A, Färkkilä A, Hynninen J, Muranen TA, Taipale J, Hautaniemi S. Afenteva D, et al. Among authors: hautaniemi s. Cell Rep Med. 2025 Sep 16;6(9):102316. doi: 10.1016/j.xcrm.2025.102316. Epub 2025 Aug 29. Cell Rep Med. 2025. PMID: 40885189 Free PMC article. Clinical Trial.
Editorial: Multi-omic Data Integration in Oncology.
Finotello F, Calura E, Risso D, Hautaniemi S, Romualdi C. Finotello F, et al. Among authors: hautaniemi s. Front Oncol. 2020 Sep 15;10:1768. doi: 10.3389/fonc.2020.01768. eCollection 2020. Front Oncol. 2020. PMID: 33042824 Free PMC article. No abstract available.
200 results